FDA approves $3.5 million gene therapy for hemophilia

The Food and Drug Administration (FDA) approved a drug to treat adults with hemophilia B, a rare blood clotting disorder.

Related Keywords

Peter Marks ,Kim Phelan ,Drug Administration ,Coalition For Hemophilia ,Associated Press ,Biologics Evaluation ,